TUG1 and hepatocellular carcinoma: Secondly, more comprehensive in vivo and in vitro studies are necessary to elucidate the mechanisms of TUG1 promotes hepatocellular carcinoma immune evasion via upregulating the JAK2/STAT3/PD-L1 signaling pathway.